CompanyInvestor RelationsStem Cell StorageCell ExpansionCell TherapiesResearch and DevelopmentCompany NewsScientific NewsContact
    
 
  • Company
  • Shareholder
  • Share Price
  • Analyst
  • Financial Reporting
  • Accounting policies
  • Calendar
  • Investor News
  • Contact
    		•
    Investor Relations / Investor News

    Announcements

    Date Title Summary 
    26/02/2010Acquisition of minority shareholdingsCryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has acquired the remaining 30% minority shareholding of its...
    26/02/2010Acquisition of minority shareholdings (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, heeft het resterende 30% minderheidsbelang gekocht van haar...
    24/02/2010Notice of Full Year resultsCryo-Save Group NV, (AIM: CRYO), Europe's largest adult stem cell storage bank, will be publishing its Full Year results for the 12 months ended 31 December 2009 on Monday, 22 March 2010.
    24/02/2010Notice of Full Year results (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, zal haar resultaat over het jaar eindigend op 31 december 2009 publiceren op maandag 22 maart 2010.
    04/02/2010New CEO AppointmentCryo-Save Group N.V. (AIM/Euronext: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has appointed Arnoud van Tulder (48) as Chief Executive Officer with effect from 1 May 2010.
    04/02/2010New CEO Appointment (Dutch Version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, kondigt aan dat Arnoud van Tulder (48), momenteel Chief Financial Officer van de Groep, met ingang van 1 mei 2010 zal worden benoemd tot Chief Executive Officer.
    27/01/2010Board ChangeCryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, announces that Werner Spinner, a non-executive director, has resigned from the Board with immediate effect.
    27/01/2010Board Change (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, maakt bekend dat Werner Spinner met ingang van heden is teruggetreden als non-executive director uit de Board of Directors.
    19/01/2010Successful completion of Cord Blood expansion project between Cryo-Save and Etablissement Francais Du Sang, FranceCryo-Save, Europe's leading stem cell bank, is pleased to announce the successful completion of a collaborative project with EFS...
    13/01/2010Transfer of Treasury SharesCryo-Save Group (AIM/Euronext: CRYO or “the Group”) announces that, on 12 January 2010, 20,000 ordinary shares have been transferred from treasury shares...
    07/01/2010Q4 2009 sample storage resultsCryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, stored over 7,300 samples in Q4 2009, up 18% over Q4 2008 (6,200 samples).
    07/01/2010Q4 2009 sample storage results (Dutch version)Cryo-Save Group N.V. (AIM/Euronext: CRYO, “Cryo-Save” of “de Groep”), de grootste stamcelbank van Europa, heeft in het vierde kwartaal van 2009 meer dan 7.300 nieuwe stalen uit navelstrengbloed van pasgeboren babies opgeslagen. Dit is een toename van meer dan 18% ten opzichte van dezelfde periode van 2008 (6.200 bloedstalen) en betekent een record voor de Groep.
    10/12/2009Cryo-Save welcomes new proposed French Law supporting Cord Blood bankingCryo-Save, Europe's leading stem cell bank, notes and welcomes the announcement of proposed new legislation in France...
    22/10/2009Admission to trading on EuronextCryo-Save Group N.V. (AIM/EURONEXT: CRYO, “Cryo-Save”, “the Company”), Europe’s leading stem cell bank, today announces commencement of dealings of its ordinary shares on Euronext Amsterdam by NYSE Euronext.
    13/10/2009Publication of the Prospectus and listing on Euronext AmsterdamCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Company”), Europe’s leading stem cell bank, announces that it has published today its prospectus as approved by the Netherlands Authority for the Financial Markets (Stichting Autoriteit Financiële Markten, "AFM") regarding the additional Euronext Amsterdam listing.
    08/10/2009Share consolidation announcementCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Company”), Europe’s leading stem cell bank, confirms that pursuant to the passing of the relevant resolutions at an EGM of the Company held on 5 October 2009, and as notified on that day, the proposed 5:1 share consolidation has this morning become effective.
    06/10/2009Q3 2009 sample storage resultsCryo-Save Group N.V. (AIM: CRYO, “Cryo-Save” or “the Group”), Europe’s leading stem cell bank, has published its Q3 2009 sample storage numbers for the quarter to 30 September 2009.
    06/10/2009EGM resolutions and share consolidationThe Group is on course to secure its additional listing on Euronext Amsterdam by mid October to complement the Group’s shares being traded on AIM in London.
    18/09/2009Cryo-Save convenes EGMCryo-Save convenes EGM in relation to intended Euronext Amsterdam listing and proposed share consolidation.
    15/09/2009Half year results 2009Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has published interim results for the six months to 30 June 2009.
    03/09/2009Cryo-Save plans to list on EuronextCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save”), Europe's leading stem cell bank, plans to seek an additional listing on Euronext Amsterdam in the fourth quarter of the current financial year to complement the Group’s shares being traded on AIM in London.
    14/08/2009Transaction in Own SharesThe Board of Cryo-Save announces that, pursuant to authorities granted by shareholders at the Company's Annual General Meeting held on 20 May 2009, the Company purchased 100,000 Ordinary Shares of Euro 0.02.
    10/08/2009Notice of ResultsCryo-Save Group NV, (AIM: CRYO, 'the Company'), Europe's largest adult stem cell storage bank, will be publishing its Interim Results for the six months ended 30 June 2009 on Tuesday, 15 September 2009.
    14/07/2009Completion of AcquisitionFurther to the announcement made on 27 May 2009, Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, is pleased to announce the completion of the acquistion of Salus Futura Ltd.
    07/07/2009Q2 Storage FiguresCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has published its Q2 2009 sample storage numbers for the quarter to 30 June 2009.
    03/07/2009Distribution agreementCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save"), Europe's leading stem cell bank, has signed an exclusive distribution agreement for the Iberian market with the Spanish subsidiary of Labco, a leading pan European medical diagnostic labs network.
    16/06/2009Directorate ChangeCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that Rob Koremans has resigned in order to take up a senior position with a leading pharmaceutical company.
    27/05/2009Acquisition of Italian service companyCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that it has agreed to acquire Salus Futura Ltd, United Kingdom, which holds all shares of Salus Futura Srl, Italy ("Salus Futura").
    20/05/2009AGM ResolutionsCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that all resolutions at today's AGM were passed.
    29/04/2009Holding(s) in CompanyTR-1: Notifications of Major Interests in Shares
    28/04/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's leading stem cell bank, has been informed that on 24 April 2009 Mr Werner Spinner, Non-Executive Director, purchased 25,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 77.24 pence per share.
    27/04/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's leading stem cell bank, has been informed that on 23 April 2009 Mr Walter van Pottelberge, Non-Executive Director, purchased 25,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 63.5 pence per share.
    24/04/2009Grant of OptionsCryo-Save Group N.V. ("Cryo-Save" or "the Company"), Europe's leading stem cell bank, announces that on 23 April 2009 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme.
    23/04/2009Annual Report and AccountsThe Company confirms that its annual report and accounts for the year ended 31 December 2008 has been posted to shareholders and is also available on the Company's website www.cryo-savegroup.com.
    22/04/2009Sale and lease backCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has signed a sale and lease back agreement for its 4,500 sq. metre laboratory and storage facility in Antwerp for 4.3 million and a 15-year fixed lease.
    07/04/2009Q1 Storage UpdateCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, has published its Q1 2009 sample storage numbers for the quarter to 31 March 2009.
    30/03/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that Mr Arnoud van Tulder, Chief Financial Officer, has today purchased 30,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 41 pence per share.
    24/03/2009Final ResultsCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, announces its final results for the year to 31 December 2008.
    24/03/2009Director/PDMR ShareholdingsThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that Rob Koremans, Chief Executive Officer, has today purchased 48,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at a price of 37p per share.
    12/03/2009100,000th sample under storageCryo-Save Group NV, (AIM: CRYO, 'the Company', "Cryo-Save"), Europe's largest adult stem cell storage bank, announces that it now has 100,000 stem cell samples under storage. This significant landmark was reached yesterday when the stem cells from the one hundred thousandth newborn child were safely stored in the Company's facilities.
    23/02/2009Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    23/02/2009Notice of ResultsCryo-Save Group NV, (AIM: CRYO, 'the Company'), Europe's largest adult stem cell storage bank, will be publishing its Final Results for the year ended 31 December 2008 on Tuesday, 24 March 2009.
    11/02/2009Proposed dividendCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading stem cell bank, announces that the Board plans to propose a maiden dividend of 0.01 per share for the year ended 31 December 2008.
    06/02/2009Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    26/01/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that on 23 January 2009 Mr Werner Spinner, Non-Executive Director, purchased 50,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 39 pence per share.
    22/01/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, has been informed that on 20 January 2009 Mr Marc Waeterschoot,Executive Chairman, purchased 101,100 ordinary shares of Euro 0.02 ("Ordinary Shares") at 39 pence per share.
    20/01/2009Transaction in Own SharesThe Board of Cryo-Save announces that the Company has today purchased 50,000 Ordinary Shares of Euro 0.02 ("Ordinary Shares") at a price of 39 pence per share to be held in Treasury.
    19/01/2009Transaction in Own SharesThe Board of Cryo-Save announces that the Company purchased 50,000 Ordinary Shares of Euro 0.02 ("Ordinary Shares") on 16 January 2009 at a price of 37.5 pence per share to be held in Treasury and 150,000 Ordinary Shares on 19 January 2009 at a price of 39 pence per share, also to be held in Treasury.
    13/01/2009Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    08/01/2009Trading updateCryo-Save Group N.V. (AIM: CRYO), Europe's leading stem cell bank, has published its 2008 including Q4 sample storage numbers for the quarter to 31 December 2008.
    06/01/2009Director/PDMR ShareholdingThe Board of Cryo-Save, Europe's largest adult stem cell storage bank, was informed on 5 January 2009 that Mr Werner Spinner, Non-Executive Director, purchased 75,000 ordinary shares of Euro 0.02 ("Ordinary Shares") at 32 pence per share between 29 December 2008 and 2 January 2009.
    23/12/2008Transaction in Own SharesThe Board of Cryo-Save announces that the Company purchased 25,000 Ordinary Shares of Euro 0.02 (Ordinary Shares) on 22 December 2008 at a price of 31 pence per share to be held in Treasury.
    23/12/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified today that Werner Spinner, a Non-Executive Director of the Company, yesterday purchased 25,000 ordinary shares in the Company at 32 pence per ordinary share.
    17/12/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") announces that on 16 and 17 December 2008 it purchased 180,000 ordinary shares at an average price of 19.95 pence per share to be held in Treasury.
    12/12/2008Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    11/12/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") was notified today that Johan Goossens, a Non-Executive Director of the Company, today purchased 500,000 ordinary shares in the Company at a price of 12 pence per ordinary share.
    10/12/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") was notified yesterday that Johan Goossens, a Non-Executive Director of the Company, between 5 December and 9 December 2008 purchased 800,000 ordinary shares in the Company at a price of 14.5 pence per ordinary share.
    09/12/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified today that Werner Spinner, a Non-Executive Director of the Company, yesterday purchased 100,000 ordinary shares in the Company at a price of14 pence per ordinary share.
    02/12/2008Holding(s) in CompanyTR-1: Notification of Major Interests in Shares
    28/11/2008Change of adviser and brokerCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has appointed Daniel Stewart & Company plc as the Company's Nominated Adviser and Broker, with immediate effect.
    27/11/2008Trading UpdateCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has published a trading update and the start of sample storage in India.
    19/11/2008Holding(s) in CompanyTR-1: Notifications of Major Interests in Shares
    30/10/2008Change of Adviser NameFollowing its change of name from Kaupthing Singer & Friedlander Capital Markets Limited to Singer Capital Markets Limited, the name of the Company's nominated adviser and corporate broker is now Singer Capital Markets Limited.
    30/10/2008Holding(s) in CompanyTR-1: Notifications of Major Interests in Shares
    23/10/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified today that Johan Goossens, a Non-Executive Director of the Company, yesterday purchased 100,000 ordinary shares in the Company at 38.30 pence per ordinary share.
    22/10/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified today that Marc Waeterschoot, the Executive Chairman of the Company, yesterday purchased 2,977,500 ordinary shares in the Company at 37.5 pence per ordinary share.
    08/10/2008Q3 sample storage numbersCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has published its Q3 sample storage numbers for the quarter to 30 September 2008.
    26/09/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified today that Marc Waeterschoot, the Executive Chairman of the Company, yesterday purchased 421,000 ordinary shares in the Company at 65 pence per ordinary share.
    25/09/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that on Wednesday 24 September 2008, Rob Koremans, the CEO of the Company, purchased 35,000 ordinary shares in the Company at 65 pence per ordinary share.
    24/09/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified today that Johan Goossens, a Non-Executive Director of the Company, yesterday purchased 100,000 ordinary shares in the Company at 71 pence per ordinary share.
    23/09/2008Interim ResultsCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has published interim results for the six months to 30 June 2008.
    21/08/2008Notice of ResultsNotice of Interim Results - 23 September 2008
    22/07/2008Acquisition of leading Balkan distributorCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save", or "the Group"), Europe's leading adult stem cell storage bank, has acquired Cryo-Save Balcanica S.A. ("Cryo-Save Balcanica") of Athens, for an initial consideration of 4.1 million payable in cash.
    08/07/2008Trading UpdateFirst half trading update - samples stored up 36%
    08/07/2008Acquisition of leading Spanish distributorCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has acquired its Spanish distributor, Crio Cord, S.L. ("Crio Cord") for an initial consideration of 16 million payable in cash.
    11/06/2008Result of AGMAGM Resolutions
    04/06/2008Launch of CryoCordCryoCord launched as storage of mesenchymal stem cells from umbilical cord tissue starts.
    22/05/2008Director/PDMR Shareholding/Grant of OptionsCryo-Save Group N.V. ("Cryo-Save" or "the Company"), Europe's largest adult stem cell storage bank, announces that on 20 May 2008 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme.
    07/05/2008Holding(s) in CompanyTR-1: Notifications of Major Interests in Shares
    28/04/2008Transaction in Own SharesOn Friday 25 April 2008, Cryo-Save Group N.V. (the "Company") acquired 200,000 of its ordinary shares at an average price of 202 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    25/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 20,000 of its ordinary shares at an average price of 200 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    21/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") today acquired 113,000 of its ordinary shares at an average price of 200 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    18/04/2008Transaction in Own Shares / Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 8,000 of its ordinary shares at an average price of 187.5 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    15/04/2008Transaction in Own Shares / Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 10,000 of its ordinary shares at an average price of 164 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    14/04/2008Transaction in Own Shares / Total Voting RightsOn Friday 11 April 2008, Cryo-Save Group N.V. (the "Company") acquired 10,000 of its ordinary shares at an average price of 165 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    11/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 94,000 of its ordinary shares at an average price of 164 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    10/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 25,000 of its ordinary shares at an average price of 154 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    10/04/2008Director/PDMR ShareholdingCryo-Save Group N.V. (the "Company") announces that it was notified on 9 April 2008 that Johan Goossens, a Non-Executive Director of the Company, yesterday purchased 1,450,000 ordinary shares in the Company at 160 pence per ordinary share.
    09/04/2008Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 745,000 of its ordinary shares at an average price of 147 pence per ordinary share. The ordinary shares purchased will be held in treasury by the Company.
    08/04/2008Preliminary resultsCryo-Save Group N.V. (AIM: CRYO, Cryo-Save or the Group), Europes leading adult stem cell storage bank, has published its preliminary results for the year to 31 December 2007 as well as its storage and new clients figures for Q1 2008.
    13/03/2008Launch in IndiaCryo-Save Group N.V. (AIM: CRYO, Cryo-Save or the Group), Europes largest adult stem cell storage bank, has established an Indian operation, Cryo-Save India Private Ltd ("Cryo-Save India"), will build a new storage laboratory in Belgium and has acquired its South African distributor CRYOCLINIC (Pty) Ltd ("Cryoclinic").
    07/03/2008Notice of ResultsCryo-Save Group NV, (AIM: CRYO, the Company), Europe's largest adult stem cell storage bank, which was admitted to AIM on 6 November 2007, will be publishing its first Preliminary results for the year ended 31 December 2007 on Tuesday, 8 April 2008.
    08/02/2008Transaction in Own Shares Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 66,500 of its ordinary shares at an average price of 190 pence per ordinary share.
    04/02/2008Transaction in Own Shares Total Voting RightsOn Friday 1st February Cryo-Save Group N.V. (the "Company") acquired 56,000 of its ordinary shares at an average price of 189 pence per ordinary share.
    01/02/2008Transaction in Own Shares Total Voting RightsCryo-Save Group N.V. (the "Company") yesterday acquired 62,500 of its ordinary shares at an average price of 187 pence per ordinary share.
    31/01/2008Acquisition of Hungarian distributor and year-end trading updateCryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's largest adult stem cell storage bank, announces that it is publishing a trading update for the year ended 31 December 2007 and that it has acquired its Hungarian distributor, Sejtbank. Cryo-Save was admitted to AIM on 6 November 2007.
    24/12/2007Transaction in Own SharesCryo-Save Group N.V. (the "Company"), on Friday 21 December 2007, acquired 50,000 of its ordinary shares at an average price of 210 pence per ordinary share.
    21/12/2007Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 25,000 of its ordinary shares at an average price of 208 pence per ordinary share.
    20/12/2007Transaction in Own SharesCryo-Save Group N.V. (the "Company") yesterday acquired 80,000 of its ordinary shares at an average price of 206 pence per ordinary share.
    10/12/2007Director/PDMR ShareholdingCryo-Save Group N.V. ("Cryo-Save" or "the Company"), Europe's largest adult stem cell storage bank, announces that on 7 December 2007 the Company granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2007 Share Option Scheme.
    13/11/2007Major Interests in SharesNotification of major interests in shares.
    06/11/2007Cryo-Save Group N.V. First day of dealingsCryo-Save Group N.V. (Cryo-Save, the Group or the Company), Europes largest adult stem cell storage bank, announces the commencement of dealings in its Ordinary Shares on AIM today under the ticker code CRYO.L and the ISIN number of NL0006091969.
    01/11/2007Cryo-Save Group N.V.: Admission to AIM with market capitalisation of 101.2mCryo-Save Group N.V. (Cryo-Save, the Group or the Company), Europes largest adult stem cell storage bank, is to be admitted to AIM with a market capitalisation of 101.17 million. The Group has raised 26.54 million, before expenses, via a placing of shares at 210p per share with institutional investors. Trading in Cryo-Save shares is expected to start on Tuesday 6 November 2007.
    		  
      europe flag
    Europe's leading stem cell bank -
    4 laboratories - 38 countries -
    3 continents


    Use of this website signifies your agreement to the Disclaimer.
    ©2009 Cryo-Save Group N.V. All rights reserved.